γ-Secretase inhibitor
- Cell-permeable, potent, and non-competitive selective inhibitor of γ-secretase and Notch pathway
- Inducer of neuronal differentiation
- Active in vitro and in vivo
γ-Secretase is a multimeric and transmembrane aspartyl protease constituted of four subunits: presenilin, nicastrin, Aph-1, and Pen-2. Presenilin is the catalytic subunit of γ-secretase. The carboxyl-terminal fragments (CTFs) of Amyloid precursor protein (APP) and of Notch are two well-known substrates of γ-secretase. Aberrant cleavage of these substrates by γ-secretase is associated with Alzheimer’s disease and cancer, respectively. g-Secretase is, therefore, a promising drug target. Compound E is a cell permeable, potent, selective, and non-competitive inhibitor of γ-secretase. It inhibits the cleavage of both APP and Notch CTFs (IC50=0.3nM for total β-amyloid). At higher concentrations (20-400µM), It only weakly affects the activity of presenilin. Compound E was shown to impede ovarian folliculogenesis, promotes neuronal differentiation, and down-regulate thymocyte development.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Product Details
Alternative Name |
(2S)-2-{[(3,5-Difluorophenyl)acetyl]amino}-N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]propanamide, γ-Secretase Inhibitor, GSI |
---|---|
Appearance |
White to off-white powder. |
CAS |
209986-17-4 |
Couple Target |
Secretase |
Couple Type |
Inhibitor |
Formula |
C27H24F2N4O3 |
Identity |
Identity determined by MS and NMR. |
MW |
490.5 |
Purity |
≥95% (HPLC) |
Solubility |
Soluble in DMSO (50 mg/ml). |
Handling & Storage
Use/Stability |
As indicated on product label or CoA when stored as recommended. Stock solutions in DMSO are stable for at least 1 month when stored at -20°C. |
---|---|
Handling |
Keep under inert gas. |
Short Term Storage |
+4°C |
Long Term Storage |
-20°C |
Shipping |
Ambient Temperature |
Regulatory Status |
RUO – Research Use Only |
---|
- The ESCRT protein CHMP5 promotes T cell leukemia by enabling BRD4-p300-dependent transcription: Umphred-Wilson, K., Ratnayake, S., et al.; Nat. Commun. 16, 4133 (2025), Abstract
- The ESCRT protein CHMP5 promotes T cell leukemia by controlling BRD4-p300-dependent transcription: Umphred-Wilson, K., Ratnayake, S., et al.; bioRxiv , (2024)
- Notch signaling regulates UNC5B to suppress endothelial proliferation, migration, junction activity, and retinal plexus branching: Raza, Q., Nadeem, T., et al.; Sci. Rep. 14, 13603 (2024), Abstract
- Neuromuscular dysfunction in patient-derived FUSR244RR-ALS iPSC model via axonal downregulation of neuromuscular junction proteins: von Kuegelgen, N., Ludwik, K., et al.; bioRxiv , (2024)
- Endothelial Notch signaling directly regulates the small GTPase RND1 to facilitate Notch suppression of endothelial migration: B. Swaminathan, et al.; Sci. Rep. 12, 1655 (2022), Abstract
- A hotspot mutation targeting the R-RAS2 GTPase acts as a potent oncogenic driver in a wide spectrum of tumors: I. Fernandez-Pisonero, et al.; Cell Rep. 38, 110552 (2022), Abstract
- Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons: G.S. Virdi, et al.; NPJ Parkinsons Dis. 8, 162 (2022), Abstract
- Cancer-associated mutations in VAV1 trigger variegated signaling outputs and T-cell lymphomagenesis: J.R. Valero, et al.; EMBO J. 40, e108125 (2021), Abstract
- A non-toxic concentration of telomerase inhibitor BIBR1532 fails to reduce TERT expression in a feeder-free induced pluripotent stem cell model of human motor neurogenesis: V.A. Pandya, et al.; Int. J. Mol. Sci. 22, 3256 (2021), Abstract — Full Text
- Comparative structural, biophysical, and receptor binding study of true type and wild type AAV2: A. Bennett, et al.; J. Struct. Biol. 213, 107795 (2021), Abstract
- Leukemia-specific delivery of mutant NOTCH1 targeted therapy.: G. Roti, et al.; J. Exp. Med. 215, 197 (2018), Abstract — Full Text
- A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia: J. Robles-Valero, et al.; Cancer Cell 32, 608 (2017), Abstract — Full Text
- Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia: Fabbri, G., Holmes, A. B., et al.; PNAS 114, E2911 (2017), Abstract
- Mechanism of BMP9 promotes growth of osteosarcoma mediated by the Notch signaling pathway: P. Liu, et al.; Oncol. Lett. 11, 1367 (2016), Application(s): Notch Inhibition in Cell Culture, Abstract — Full Text
- A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies: Ortega, M., Bhatnagar, H., et al.; Leukemia 29, 968 (2015), Abstract
- Necrosis- and apoptosis-related Met cleavages have divergent functional consequences: R. Montagne, et al.; Cell Death Dis. 6, e1769 (2015), Application(s): Cell Culture, Abstract — Full Text
- Cyclin C is a haploinsufficient tumour suppressor: Li, N., Fassl, A., et al.; Nat. Cell Biol. 16, 1080 (2014), Abstract
- The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability: King, B., Trimarchi, T., et al.; Cell 153, 1552 (2013), Abstract
- Notch1 receptor regulates AKT protein activation loop (Thr308) dephosphorylation through modulation of the PP2A phosphatase in phosphatase and tensin homolog (PTEN)-null T-cell acute lymphoblastic leukemia cells: Hales, E. C., Orr, S. M., et al.; J. Biol. Chem. 288, 22836 (2013), Abstract
- Modulation of gene expression via overlapping binding sites exerted by ZNF143, Notch1 and THAP11: Ngondo-Mbongo, R. P., Myslinski, E., et al.; Nucleic Acids Res. 41, 4000 (2013), Abstract
- Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling: Guijarro, M. V., Dahiya, S., et al.; Am. J. Pathol. 182, 2015 (2013), Abstract
- An activating intragenic deletion in NOTCH1 in human T-ALL: Haydu, J. E., De Keersmaecker, K., et al.; Blood 119, 5211 (2012), Abstract
- Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling: Tan, M. J., White, E. A., et al.; PNAS 109, E1473 (2012), Abstract
- Notch signaling regulates mouse and human Th17 differentiation: Keerthivasan, S., Suleiman, R., et al.; J. Immunol. 187, 692 (2011), Abstract
- Gene deletion screen for cardiomyopathy in adult Drosophila identifies a new notch ligand: I.M. Kim, et al.; Circ. Res. 106, 1233 (2010), Abstract
- Molecular profiling reveals diversity of stress signal transduction cascades in highly penetrant Alzheimer’s disease human skin fibroblasts: Mendonsa, G., Dobrowolska, J., et al.; PLoS One 4, e4655 (2009), Abstract
- Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria: Area-Gomez, E., de Groof, A. J., et al.; Am. J. Pathol. 175, 1810 (2009), Abstract
- Synaptic activity prompts gamma-secretase-mediated cleavage of EphA4 and dendritic spine formation: E. Inoue, et al.; J. Cell. Biol. 185, 551 (2009), Abstract
- Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis: B. Foveau, et al.; Mol. Biol. Cell 20, 2495 (2009), Abstract
- Determination of guinea-pig cortical gamma-secretase activity ex vivo following the systemic administration of a gamma-secretase inhibitor: S. Grimwood, et al.; Neuropharmacology 48, 1002 (2005), Abstract
- Linking receptor-mediated endocytosis and cell signaling: evidence for regulated intramembrane proteolysis of megalin in proximal tubule: Z. Zou, et al.; J. Biol. Chem. 279, 34302 (2004), Abstract — Full Text
- Identification of a new presenilin-dependent zeta-cleavage site within the transmembrane domain of amyloid precursor protein: G. Zhao, et al.; J. Biol. Chem. 279, 50647 (2004), Abstract — Full Text
- Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria: C.A. Hansson, et al.; J. Biol. Chem. 279, 51654 (2004), Abstract — Full Text
- Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia: A.P. Weng, et al.; Science 306, 269 (2004), Abstract
- Presenilin-dependent gamma-secretase activity mediates the intramembranous cleavage of CD44: D. Murakami, et al.; Oncogene 22, 1511 (2003), Abstract
- Regulated intramembrane proteolysis of the p75 neurotrophin receptor modulates its association with the TrkA receptor: K.M. Jung, et al.; J. Biol. Chem. 278, 42161 (2003), Abstract — Full Text
- Linear non-competitive inhibition of solubilized human gamma-secretase by pepstatin A methylester, L685458, sulfonamides, and benzodiazepines: G. Tian, et al.; J. Biol. Chem. 277, 31499 (2002), Abstract — Full Text
- aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation: R. Francis, et al.; Dev. Cell 3, 85 (2002), Abstract
- Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4: H.J. Lee, et al.; J. Biol. Chem. 277, 6318 (2002), Abstract — Full Text
- Pharmacological knock-down of the presenilin 1 heterodimer by a novel gamma -secretase inhibitor: implications for presenilin biology: D. Beher, et al.; J. Biol. Chem. 276, 45394 (2001), Abstract — Full Text
- Presenilin-dependent gamma-secretase activity modulates thymocyte development: P. Doerfler, et al.; PNAS 98, 9312 (2001), Abstract — Full Text
- gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase: C.Y. Ni, et al.; Science 294, 2179 (2001), Abstract
- Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors: D. Seiffert, et al.; J. Biol. Chem. 275, 34086 (2000), Abstract — Full Text
Related Products

Alternative Name | Amyloid A4 protein, Amyloid protein |
---|---|
Application | WB |
Host | Mouse |
Isotype | IgG1 |
Species Reactivity | Human, Mouse |

Alternative Name | Amyloid A4 protein, Amyloid protein |
---|---|
Application | IHC, WB |
Host | Rabbit |
Species Reactivity | Human, Mouse, Rat |

Alternative Name | N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester, γ-Secretase inhibitor IX |
---|---|
CAS | 208255-80-5 |
Couple Type | Inhibitor |
Purity | ≥98% (HPLC) |

Alternative Name | Z-5-Fluoro-2-methyl-1-[p-(methylthio)benzylidene]indene-3-acetic acid |
---|---|
CAS | 32004-67-4 |
Couple Type | Inhibitor |
Purity | ≥99% (TLC) |
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form